Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus.


BACKGROUND/PURPOSE Exenatide has been predominantly studied in non-Asian populations. The purpose of this study was to investigate the safety and efficacy of twice-daily (BID) exenatide versus placebo in a subpopulation of Taiwanese patients from a larger study on Asian patients. METHODS Patients unable to achieve glycemic control with metformin alone or… (More)
DOI: 10.1016/j.jfma.2012.02.027


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics